What is the CVSS score of CVE-2017-17677?

CVE-2017-17677 has a CVSS 3.1 base score of 8.8 (High). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 1.3%.

Remedy Mid Tier CVE-2017-17677

HIGH

Incorrect Permission Assignment for Critical Resource (CWE-732)

2021-05-19 cve@mitre.org

RCE Remedy Mid Tier

8.8

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

8.8 HIGH

AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Network

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

May 19, 2021 - 14:15 nvd

HIGH 8.8

DescriptionNVD

BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code.

AnalysisAI

BMC Remedy 9.1SP3 is affected by authenticated code execution. Rated high severity (CVSS 8.8), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified as Incorrect Permission Assignment (CWE-732), which allows attackers to access resources due to misconfigured permissions. BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code. Affected products include: Bmc Remedy Mid-Tier.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Review and restrict file/resource permissions, apply principle of least privilege.